BMRA

Value Q1, 25Q2, 25Q3, 25 TTM Total revenue 1.38 M1.21 M987 K 4.33 M Gross profit 424 K51 K-44 K 184 K Operating expenses 1.54 M1.42 M1.25 M 5.54 M Selling/general/admin expenses 1.33 M1.23 M1.08 M 4.7 M Research & development 212 K193 K178 K 835 K Operating income -1.12 M-1.37 M-1.3 M -5.36 M Non-Operating Income, Total 1.12 M58 K-6 000 1.2 M Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses 1.12 M58 K0 1.21 M Unusual income/expense ——-6 000 — Pretax income 5 000-1.31 M-1.3 M -4.15 M Equity in earnings ——— — Taxes 3 0005 0008 000 20 K Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 2 000-1.32 M-1.31 M -4.17 M Discontinued operations ——— — Net income 2 000-1.32 M-1.31 M -4.17 M Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 2 000-1.32 M-1.31 M -4.17 M Basic earnings per share (Basic EPS) 0-0.45-0.44 -1.88 Diluted earnings per share (Diluted EPS) 0-0.45-0.44 -1.88 Average basic shares outstanding 2.64 M2.91 M3.01 M — Diluted shares outstanding 2.64 M2.91 M3.01 M — EBITDA -1.11 M-1.37 M-1.29 M -5.31 M EBIT -1.12 M-1.37 M-1.3 M -5.36 M Cost of revenue 956 K1.16 M1.03 M 4.14 M Other cost of goods sold ——— — Depreciation & amortization (cash flow) 5 0005 0006 000 37 K